R21 Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
August 1, 2021
End Date
July 31, 2024
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
August 1, 2021
End Date
July 31, 2024